RICTOR amplification identifies a subgroup in small cell lung cancer and predicts response to drugs targeting mTOR.
about
Rapamycin (mTORC1 inhibitor) reduces the production of lactate and 2-hydroxyglutarate oncometabolites in IDH1 mutant fibrosarcoma cellsClinical significance and effect of AEG-1 on the proliferation, invasion, and migration of NSCLC: a study based on immunohistochemistry, TCGA, bioinformatics, in vitro and in vivo verification.Inhibiting 4EBP1 in glioblastoma.Classification of pulmonary neuroendocrine tumors: new insights.RAPTOR up-regulation contributes to resistance of renal cancer cells to PI3K-mTOR inhibition.The role of RICTOR downstream of receptor tyrosine kinase in cancers.
P2860
RICTOR amplification identifies a subgroup in small cell lung cancer and predicts response to drugs targeting mTOR.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
RICTOR amplification identifie ...... ponse to drugs targeting mTOR.
@en
RICTOR amplification identifie ...... ponse to drugs targeting mTOR.
@nl
type
label
RICTOR amplification identifie ...... ponse to drugs targeting mTOR.
@en
RICTOR amplification identifie ...... ponse to drugs targeting mTOR.
@nl
prefLabel
RICTOR amplification identifie ...... ponse to drugs targeting mTOR.
@en
RICTOR amplification identifie ...... ponse to drugs targeting mTOR.
@nl
P2093
P2860
P356
P1433
P1476
RICTOR amplification identifie ...... ponse to drugs targeting mTOR.
@en
P2093
Adam Kresak
Afshin Dowlati
Michael Yang
Mohadese Behtaj
Nneha Sakre
P2860
P304
P356
10.18632/ONCOTARGET.13362
P407
P577
2016-11-15T00:00:00Z